Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXEL3I
|
||||
| Drug Name |
4-[(4-Fluorophenyl)methyl]-2-{[(2R)-1-methyl-2-pyrrolidinyl]methyl}-1(2H)-phthalazinone
|
||||
| Synonyms |
CHEMBL1767140
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H22FN3O
|
||||
| Canonical SMILES |
CN1CCC[C@@H]1CN2N=C(Cc3ccc(F)cc3)c4ccccc4C2=O
|
||||
| InChI |
InChI=1S/C21H22FN3O/c1-24-12-4-5-17(24)14-25-21(26)19-7-3-2-6-18(19)20(23-25)13-15-8-10-16(22)11-9-15/h2-3,6-11,17H,4-5,12-14H2,1H3/t17-/m1/s1
|
||||
| InChIKey |
DCGYGKIBQOAKTB-QGZVFWFLSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.